Educational Series: Which Technology Should You Choose for Pharmacogenomics Testing?

Learn the fundamentals of PGx, compare PCR, multiplex, and sequencing-based technologies, and explore the practical tradeoffs involved in implementing a successful testing strategy

As pharmacogenomic (PGx) testing becomes an increasingly important component of precision medicine, molecular laboratories face a growing range of technology options, each with unique strengths, limitations, and implementation considerations.

This four-part educational whitepaper series provides a practical framework for understanding today's PGx testing technologies, from foundational concepts through technology selection and implementation. Begin with a complimentary introduction to PGx testing fundamentals, then complete the form to access three in-depth papers exploring PCR-based methods, multiplex and sequencing-based approaches, and practical guidance for choosing the right technology for your laboratory.

Whether you're evaluating new PGx capabilities or expanding an existing testing program, this educational series provides practical insights to help laboratories navigate the PGx technology landscape and make informed implementation decisions.

After completing this series, readers will be able to:

  • Describe the major technologies used in pharmacogenomic testing and where they fit in the clinical laboratory.
  • Compare the strengths, limitations, and applications of targeted, multiplex, and sequencing-based PGx approaches.
  • Apply practical considerations for selecting and implementing PGx technologies based on laboratory and clinical needs.

Access the free overview: Pharmacogenomic Testing Fundamentals for the Molecular Laboratory

Build a strong foundation in pharmacogenomics with an overview of the clinical role of PGx testing, the major molecular technology categories used today, and the key considerations for implementing PGx workflows in the laboratory.


Complete the form to unlock the rest of the series. 

Continue your learning with three in-depth whitepapers covering:

  • Rapid and Targeted PGx Technologies for Clinical Testing: Explore quantitative PCR (qPCR) and digital PCR (dPCR), including technology principles, clinical applications, strengths, limitations, and ideal use cases for rapid, targeted PGx testing.
  • Multiplex and Sequencing-Based Approaches for PGx Testing: Learn how microarrays, MALDI-TOF mass spectrometry, capillary electrophoresis, and next-generation sequencing support multiplexed and comprehensive PGx testing strategies.
  • Choosing and Implementing PGx Technologies: Compare technology tradeoffs and learn practical approaches for selecting, validating, and implementing PGx testing platforms based on clinical needs, laboratory workflows, scalability, and long-term strategy.


I am interested in implementing a PGx workflow solution within the next 6–12 months:


サーモフィッシャーサイエンティフィックジャパングループ各社は取得した個人情報を弊社の個人情報保護方針に従い利用し、安全かつ適切に管理します。詳細は個人情報の取扱いについてをご確認ください。

 

イベント、製品/サービス、キャンペーン情報等のメール/テキストメッセージ配信・DM送付(※1)をご希望されますか?(※2)*

 

(※1) メール/テキストメッセージ配信・DM送付は、サーモフィッシャージャパングループ各社のほか、本邦外に所在する他の Thermo Fisher Scientificグループ企業からさせていただく場合もございます。ご了承下さい。
(※2) 現在受信されている方も、今後続けて配信をご希望の場合はチェックをお願いします。

お申し込み/ご応募の際は、このページに記載のすべての注意事項に同意いただいたものとみなされます。